Northern Trust Corp Chembio Diagnostics, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.25 - $0.45 $254 - $458
-1,019 Reduced 1.24%
81,124 $35,000
Q1 2022

May 13, 2022
SELL
$0.66 - $1.23 $724 - $1,349
-1,097 Reduced 1.32%
82,143 $67,000
Q4 2021

Feb 08, 2022
SELL
$1.09 - $2.55 $656 - $1,535
-602 Reduced 0.72%
83,240 $95,000
Q3 2021

Nov 15, 2021
BUY
$2.06 - $5.34 $12,465 - $32,312
6,051 Added 7.78%
83,842 $210,000
Q2 2021

Aug 13, 2021
SELL
$2.88 - $5.64 $480,381 - $940,746
-166,799 Reduced 68.2%
77,791 $231,000
Q1 2021

May 12, 2021
SELL
$3.4 - $7.97 $160,915 - $377,204
-47,328 Reduced 16.21%
244,590 $858,000
Q4 2020

Feb 11, 2021
SELL
$4.11 - $7.51 $43,183 - $78,907
-10,507 Reduced 3.47%
291,918 $1.39 Million
Q3 2020

Nov 16, 2020
BUY
$3.28 - $5.93 $447,254 - $808,602
136,358 Added 82.11%
302,425 $1.47 Million
Q2 2020

Aug 14, 2020
BUY
$3.18 - $15.54 $383,453 - $1.87 Million
120,583 Added 265.11%
166,067 $539,000
Q1 2020

May 14, 2020
BUY
$2.36 - $5.6 $3,176 - $7,537
1,346 Added 3.05%
45,484 $233,000
Q4 2019

Feb 14, 2020
SELL
$3.94 - $5.76 $329,569 - $481,806
-83,647 Reduced 65.46%
44,138 $201,000
Q3 2019

Nov 13, 2019
BUY
$4.84 - $7.25 $382,422 - $572,844
79,013 Added 162.0%
127,785 $783,000
Q1 2019

May 13, 2019
SELL
$5.32 - $7.18 $27,110 - $36,589
-5,096 Reduced 9.46%
48,772 $271,000
Q4 2018

Feb 12, 2019
BUY
$4.95 - $10.5 $85,427 - $181,209
17,258 Added 47.14%
53,868 $305,000
Q3 2018

Nov 14, 2018
BUY
$9.2 - $11.5 $123,427 - $154,284
13,416 Added 57.84%
36,610 $384,000
Q2 2018

Aug 14, 2018
BUY
$7.8 - $11.1 $24,640 - $35,064
3,159 Added 15.77%
23,194 $257,000
Q1 2018

May 09, 2018
BUY
$7.05 - $9.0 $9,165 - $11,700
1,300 Added 6.94%
20,035 $160,000
Q4 2017

Feb 14, 2018
BUY
$5.95 - $8.35 $11 - $16
2 Added 0.01%
18,735 $154,000
Q3 2017

Nov 13, 2017
BUY
$5.85 - $6.2 $109,588 - $116,144
18,733
18,733 $116,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email